Pricing Log in Create free account

BioVie Inc. (BIVI) vs MetaVia Inc. (MTVA)

BioVie Inc. and MetaVia Inc. are both Biotechnology companies. BioVie Inc. and MetaVia Inc. are of similar size ($9.6M and $9.0M). Across the 9 metrics below, MetaVia Inc. leads on 5 and BioVie Inc. on 4.

Valuation

Metric BIVI MTVA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.85 1.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.09 0.64
EV/Sales n/m n/m 9.21
Earnings yield (262.50%) (178.24%) (33.15%)
Free cash flow yield (218.80%) (211.89%) (25.50%)

Profitability

Metric BIVI MTVA Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (151.06%) (175.68%) (56.36%)
Return on assets (123.51%) (91.06%) (48.04%)
Return on invested capital (1,095.01%) 0.00% 0.00%

Growth

Metric BIVI MTVA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 74.83% 81.23% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI MTVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.59 2.06 4.72
Net debt to EBITDA 0.40 0.75 0.96

Dividend

Metric BIVI MTVA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BIVI MTVA Biotechnology median
Market cap 9.64m 9.03m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack